Skip to main content
Top
Published in: BMC Gastroenterology 1/2008

Open Access 01-12-2008 | Research article

Immunohistochemical testing for Helicobacter Pyloriexistence in neoplasms of the colon

Authors: Aliye Soylu, Selvinaz Ozkara, Halil Alıs, Kemal Dolay, Mustafa Kalaycı, Nurgul Yasar, A Baki Kumbasar

Published in: BMC Gastroenterology | Issue 1/2008

Login to get access

Abstract

Background

Helicobacter pylori is a common pathogen, and its prevalence varies with socioeconomic conditions (10–80%). It has recently been recognized as a class I carcinogen in relation to gastric cancer. The aim of this study was to investigate the presence of Helicobacter pylori in neoplasms of the colon by immunohistochemical methods.

Methods

The polypectomy materials of 51 patients (19 male and 32 female) who had undergone colonoscopic polypectomy were retrieved for retrospective examination. The endoscopic size and colonic localization of the polyps were recorded. Hematoxylin and eosin stains were evaluated according to histological type and grade of dysplasia. Biopsy stains were immunohistochemically treated with Helicobacter pylori antibodies by the streptavidine-biotin immunoperoxidase technique. Helicobacter pylori staining in the gastric mucosa was used as the control for the immunohistochemical method. Specimens were classified according to the presence of Helicobacter pylori under an optical microscope, and Helicobacter pylori positive specimens were stratified according to the respective staining pattern.

Results

Mean age was 61.88 ± 10.62 (40–82) years. Polyp sizes were 1.45 ± 0.92 (1–4) cm; and 25.5% of polyps were localized in the right colon, 68.6% in the left colon and 5.9% in the transverse colon. Presence of Helicobacter pylori was not correlated with localization (p > 0.05) or size of the polyps (p > 0.05).
Eleven (21.6%) of all specimens included in the study were Helicobacter pylori positive by immunohistochemical methods. Of the Helicobacter pylori positive specimens, the staining pattern was diffuse: Equivocal in 90.9%, nonspecific with a finely granular type concentrated on the luminal surface in 90.9%, dot-like granular in 54.5%, and spiral in 9.1%. Of the tubular polyps, 17.9% were H. pylori positive, and the staining pattern was equivocal in 100%, luminal in 85.7%, and dot-like granular in 57.1%. Of the villous polyps, 60% were H. pylori positive, and the staining pattern was inconclusive in 66.7%, luminal in 100%, dot-like granular in 33.3%, and spiral in 33.3%. Of the cancerous cases, 25% were H. pylori positive and showed an equivocal, luminal, and dot-like granular staining pattern. No significant correlation was determined between histologic types and prevalence of H. pylori (p > 0.05).

Conclusion

The presence of H. pylori in colon polyps did not yield any correlation with polyp size, colonic localization or histopathologic type. The higher rate of H. pylori positivity in villous polyps does not present a causal relationship. We were able to determine H. pylori existence in colon polyps by immunohistochemical methods, albeit with no statistical significance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991, 325: 1127-1131.CrossRefPubMed Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991, 325: 1127-1131.CrossRefPubMed
2.
go back to reference Gologan A, Graham DY, Sepulveda AR: Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005, 25: 197-222. 10.1016/j.cll.2004.12.002.CrossRefPubMed Gologan A, Graham DY, Sepulveda AR: Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005, 25: 197-222. 10.1016/j.cll.2004.12.002.CrossRefPubMed
3.
go back to reference Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadström T: Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol. 2000, 38: 1072-1076.PubMedPubMedCentral Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadström T: Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol. 2000, 38: 1072-1076.PubMedPubMedCentral
4.
go back to reference Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM: Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res. 2006, 66: 828-838. 10.1158/0008-5472.CAN-05-2448.CrossRefPubMed Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM: Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res. 2006, 66: 828-838. 10.1158/0008-5472.CAN-05-2448.CrossRefPubMed
5.
go back to reference Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA: Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther. 2003, 18: 481-486. 10.1046/j.1365-2036.2003.01703.x.CrossRefPubMed Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA: Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther. 2003, 18: 481-486. 10.1046/j.1365-2036.2003.01703.x.CrossRefPubMed
6.
go back to reference Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, Fox JG: CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol. 2003, 162: 691-702.CrossRefPubMedPubMedCentral Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, Fox JG: CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol. 2003, 162: 691-702.CrossRefPubMedPubMedCentral
7.
go back to reference Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J: Helicobacter pylori in colorectal neoplasm: is there an aetiological relationship?. World J Surg Oncol. 2007, 5: 51-10.1186/1477-7819-5-51.CrossRefPubMedPubMedCentral Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J: Helicobacter pylori in colorectal neoplasm: is there an aetiological relationship?. World J Surg Oncol. 2007, 5: 51-10.1186/1477-7819-5-51.CrossRefPubMedPubMedCentral
8.
go back to reference Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE: Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 2006, 66: 7395-7400. 10.1158/0008-5472.CAN-06-0558.CrossRefPubMed Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE: Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 2006, 66: 7395-7400. 10.1158/0008-5472.CAN-06-0558.CrossRefPubMed
9.
go back to reference Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H: Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion. 1999, 60: 210-215. 10.1159/000007661.CrossRefPubMed Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H: Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion. 1999, 60: 210-215. 10.1159/000007661.CrossRefPubMed
10.
go back to reference Bulajic M, Stimec B, Jesenofsky R, Kecmanovic D, Ceranic M, Kostic N, Schneider-Brachert W, Lowenfels A, Maisonneuve P, Löhr JM: Helicobacter pylori in colorectal carcinoma tissue. Cancer Epidemiol Biomarkers Prev. 2007, 16: 631-633. 10.1158/1055-9965.EPI-06-1031.CrossRefPubMed Bulajic M, Stimec B, Jesenofsky R, Kecmanovic D, Ceranic M, Kostic N, Schneider-Brachert W, Lowenfels A, Maisonneuve P, Löhr JM: Helicobacter pylori in colorectal carcinoma tissue. Cancer Epidemiol Biomarkers Prev. 2007, 16: 631-633. 10.1158/1055-9965.EPI-06-1031.CrossRefPubMed
11.
go back to reference Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB: Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol. 2001, 96: 84-88. 10.1111/j.1572-0241.2001.03355.x.CrossRefPubMed Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB: Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol. 2001, 96: 84-88. 10.1111/j.1572-0241.2001.03355.x.CrossRefPubMed
13.
go back to reference Parsonnet J: Helicobacter pylori. Infect Dis Clin North Am. 1998, 12: 185-97. 10.1016/S0891-5520(05)70417-7.CrossRefPubMed Parsonnet J: Helicobacter pylori. Infect Dis Clin North Am. 1998, 12: 185-97. 10.1016/S0891-5520(05)70417-7.CrossRefPubMed
14.
go back to reference Testino G, Cornaggia M, Valentini M: Helicobacter pylori, pre-neoplastic changes, gastric cancer: a point of view. Eur J Gastroenterol Hepatol. 1999, 11: 357-359. 10.1097/00042737-199903000-00024.CrossRefPubMed Testino G, Cornaggia M, Valentini M: Helicobacter pylori, pre-neoplastic changes, gastric cancer: a point of view. Eur J Gastroenterol Hepatol. 1999, 11: 357-359. 10.1097/00042737-199903000-00024.CrossRefPubMed
15.
go back to reference Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN: Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992, 33: 16-20. 10.1136/gut.33.1.16.CrossRefPubMedPubMedCentral Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN: Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992, 33: 16-20. 10.1136/gut.33.1.16.CrossRefPubMedPubMedCentral
16.
go back to reference Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, Furui J, Kanematsu T: Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis. 2002, 23: 1927-1931. 10.1093/carcin/23.11.1927.CrossRefPubMed Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, Furui J, Kanematsu T: Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis. 2002, 23: 1927-1931. 10.1093/carcin/23.11.1927.CrossRefPubMed
17.
go back to reference Leong RW, Sung JJ: Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther. 2002, 16: 1037-1045. 10.1046/j.1365-2036.2002.01282.x.CrossRefPubMed Leong RW, Sung JJ: Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther. 2002, 16: 1037-1045. 10.1046/j.1365-2036.2002.01282.x.CrossRefPubMed
18.
go back to reference Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J: Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 2001, 96: 3406-3410. 10.1111/j.1572-0241.2001.05342.x.CrossRefPubMed Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J: Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 2001, 96: 3406-3410. 10.1111/j.1572-0241.2001.05342.x.CrossRefPubMed
19.
go back to reference Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A: Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J. 2000, 2: 6-9.PubMed Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A: Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J. 2000, 2: 6-9.PubMed
20.
go back to reference Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A: Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer. 2005, 117: 1058-1059. 10.1002/ijc.21280.CrossRefPubMed Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A: Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer. 2005, 117: 1058-1059. 10.1002/ijc.21280.CrossRefPubMed
21.
go back to reference Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, de Franchis R: High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol. 1997, 25: 605-607. 10.1097/00004836-199712000-00011.CrossRefPubMed Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, de Franchis R: High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol. 1997, 25: 605-607. 10.1097/00004836-199712000-00011.CrossRefPubMed
22.
go back to reference Oiya H, Okawa K, Aoki T, Nebiki H, Inoue T: Cap polyposis cured by Helicobacter pylori eradication therapy. J Gastroenterol. 2002, 37: 463-466. 10.1007/s005350200067.CrossRefPubMed Oiya H, Okawa K, Aoki T, Nebiki H, Inoue T: Cap polyposis cured by Helicobacter pylori eradication therapy. J Gastroenterol. 2002, 37: 463-466. 10.1007/s005350200067.CrossRefPubMed
23.
go back to reference Akamatsu T, Nakamura N, Kawamura Y, Shinji A, Tateiwa N, Ochi Y, Katsuyama T, Kiyosawa K: Possible relationship between Helicobacter pylori infection and cap polyposis of the colon. Helicobacter. 2004, 9: 651-656. 10.1111/j.1083-4389.2004.00273.x.CrossRefPubMed Akamatsu T, Nakamura N, Kawamura Y, Shinji A, Tateiwa N, Ochi Y, Katsuyama T, Kiyosawa K: Possible relationship between Helicobacter pylori infection and cap polyposis of the colon. Helicobacter. 2004, 9: 651-656. 10.1111/j.1083-4389.2004.00273.x.CrossRefPubMed
24.
go back to reference Wang KX, Wang XF, Penq JL, Cui YB, Wang J, Li CP: Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors. World J Gastroenterol. 2003, 9: 2501-2504.PubMedPubMedCentral Wang KX, Wang XF, Penq JL, Cui YB, Wang J, Li CP: Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors. World J Gastroenterol. 2003, 9: 2501-2504.PubMedPubMedCentral
25.
go back to reference Grahn N, Hmani-Aifa M, Fransén K, Söderkvist P, Monstein HJ: Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol. 2005, 54: 1031-1035. 10.1099/jmm.0.46122-0.CrossRefPubMed Grahn N, Hmani-Aifa M, Fransén K, Söderkvist P, Monstein HJ: Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol. 2005, 54: 1031-1035. 10.1099/jmm.0.46122-0.CrossRefPubMed
26.
go back to reference Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA: Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst. 1995, 87: 762-763. 10.1093/jnci/87.10.762.CrossRefPubMed Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA: Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst. 1995, 87: 762-763. 10.1093/jnci/87.10.762.CrossRefPubMed
27.
go back to reference Luzza F, Maletta M, Imeneo M, Monteleone G, Marasco R, Biancone L, Pallone F: Evidence against colonic mucosa colonisation by Helicobacter pylori. Lack of a specific antibody response in homogenates of rectal endoscopic biopsies. Ital J Gastroenterol. 1996, 28: 447-451.PubMed Luzza F, Maletta M, Imeneo M, Monteleone G, Marasco R, Biancone L, Pallone F: Evidence against colonic mucosa colonisation by Helicobacter pylori. Lack of a specific antibody response in homogenates of rectal endoscopic biopsies. Ital J Gastroenterol. 1996, 28: 447-451.PubMed
28.
go back to reference Jang TJ, Kim JR, Kim DH: Adherence of Helicobacter pylori to areas of type II intestinal metaplasia in Korean gastric mucosa. Yonsei Med J. 1999, 40: 392-395.CrossRefPubMed Jang TJ, Kim JR, Kim DH: Adherence of Helicobacter pylori to areas of type II intestinal metaplasia in Korean gastric mucosa. Yonsei Med J. 1999, 40: 392-395.CrossRefPubMed
29.
go back to reference Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF: Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000, 53: 756-759. 10.1136/jcp.53.10.756.CrossRefPubMedPubMedCentral Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF: Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000, 53: 756-759. 10.1136/jcp.53.10.756.CrossRefPubMedPubMedCentral
30.
go back to reference Marzio L, Angelucci D, Grossi L, Diodoro MG, Di Campli E, Cellini L: Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. Am J Gastroenterol. 1998, 93: 223-226. 10.1111/j.1572-0241.1998.00223.x.CrossRefPubMed Marzio L, Angelucci D, Grossi L, Diodoro MG, Di Campli E, Cellini L: Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. Am J Gastroenterol. 1998, 93: 223-226. 10.1111/j.1572-0241.1998.00223.x.CrossRefPubMed
31.
go back to reference Saito N, Sato F, Kato M, Takeda H, Sugiyama T, Asaka M: What does the positivity of a monoclonal antibody against H. pylori mean?. Helicobacter. 1998, 3: 143-PubMed Saito N, Sato F, Kato M, Takeda H, Sugiyama T, Asaka M: What does the positivity of a monoclonal antibody against H. pylori mean?. Helicobacter. 1998, 3: 143-PubMed
32.
go back to reference Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, Guadagnini S, Prévost MC, Mengin-Lecreulx D, Labigne A, Boneca IG: Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog. 2006, 2: e97-10.1371/journal.ppat.0020097.CrossRefPubMedPubMedCentral Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, Guadagnini S, Prévost MC, Mengin-Lecreulx D, Labigne A, Boneca IG: Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog. 2006, 2: e97-10.1371/journal.ppat.0020097.CrossRefPubMedPubMedCentral
33.
go back to reference Shand AG, Taylor AC, Banerjee M, Lessels A, Coia J, Clark C, Haites N, Ghosh S: Gastric fundic gland polyps in south-east Scotland: absence of adenomatous polyposis coli gene mutations and a strikingly low prevalence of Helicobacter pylori infection. J Gastroenterol Hepatol. 2002, 17: 1161-1164. 10.1046/j.1440-1746.2002.02863.x.CrossRefPubMed Shand AG, Taylor AC, Banerjee M, Lessels A, Coia J, Clark C, Haites N, Ghosh S: Gastric fundic gland polyps in south-east Scotland: absence of adenomatous polyposis coli gene mutations and a strikingly low prevalence of Helicobacter pylori infection. J Gastroenterol Hepatol. 2002, 17: 1161-1164. 10.1046/j.1440-1746.2002.02863.x.CrossRefPubMed
34.
go back to reference Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN: Subtypes of intestinal metaplasia and Helicobacter pylori. Gut. 1992, 33: 597-600. 10.1136/gut.33.5.597.CrossRefPubMedPubMedCentral Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN: Subtypes of intestinal metaplasia and Helicobacter pylori. Gut. 1992, 33: 597-600. 10.1136/gut.33.5.597.CrossRefPubMedPubMedCentral
35.
go back to reference Genta RM: Helicobacter pylori as a protomer of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol. 1995, 7: 25-30. Genta RM: Helicobacter pylori as a protomer of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol. 1995, 7: 25-30.
36.
go back to reference Genta RM, Gürer IE, Graham DY, Krishnan B, Segura AM, Gutierrez O, Kim JG, Burchette JL: Adherence of Helicobacter pylori to areas of incomplete metaplasia in the gastric mucosa. Gastroenterology. 1996, 111: 1206-1211. 10.1053/gast.1996.v111.pm8898634.CrossRefPubMed Genta RM, Gürer IE, Graham DY, Krishnan B, Segura AM, Gutierrez O, Kim JG, Burchette JL: Adherence of Helicobacter pylori to areas of incomplete metaplasia in the gastric mucosa. Gastroenterology. 1996, 111: 1206-1211. 10.1053/gast.1996.v111.pm8898634.CrossRefPubMed
37.
go back to reference Jung A, Vieth M, Maier O, Stolte M: Fundic gland polyps (Elster's cysts) of the gastric mucosa. A marker for colorectal epithelial neoplasia?. Pathol Res Pract. 2002, 198: 731-734. 10.1078/0344-0338-00328.CrossRefPubMed Jung A, Vieth M, Maier O, Stolte M: Fundic gland polyps (Elster's cysts) of the gastric mucosa. A marker for colorectal epithelial neoplasia?. Pathol Res Pract. 2002, 198: 731-734. 10.1078/0344-0338-00328.CrossRefPubMed
Metadata
Title
Immunohistochemical testing for Helicobacter Pyloriexistence in neoplasms of the colon
Authors
Aliye Soylu
Selvinaz Ozkara
Halil Alıs
Kemal Dolay
Mustafa Kalaycı
Nurgul Yasar
A Baki Kumbasar
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2008
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-8-35

Other articles of this Issue 1/2008

BMC Gastroenterology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.